In vivo assessment of non-dopaminergic systems in Parkinson's disease with Positron Emission Tomography
Parkinson's disease (PD) is characterized by a progressive loss of nigrostriatal dopaminergic neurons. Non-dopaminergic neurotransmission is also impaired. Intraneuronal Lewy bodies, the pathological hallmark of PD, have been observed in serotoninergic, noradrenergic, and cholinergic neurons. D...
Main Author: | Pavese, Nicola |
---|---|
Other Authors: | Brooks, David |
Published: |
Imperial College London
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.535608 |
Similar Items
-
In vivo assessment of pathology in Parkinson's disease with Positron Emission Tomography
by: Simpson, Benjamin
Published: (2014) -
The medical treatment of Parkinson's disease with special reference to the clinical pharmacology of dopaminergic systems
by: Lees, A. J.
Published: (1979) -
Synthesis and characterisation of a radioligand for positron emission tomography imaging of the 5-HT 1A receptor
by: McCardle, Caroline
Published: (2015) -
The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson's disease
by: Ailane, Sara
Published: (2012) -
Computerised assessment and monitoring of Parkinson's Disease
by: Cunningham, Laura Marie
Published: (2010)